Youssef Sari

Deviations in brain early serotonergic development as a result of fetal alcohol exposure.

Moderate alcohol exposure compromises neural tube midline development in prenatal brain.

Serotonin and its transporter on proliferation of fetal heart cells.

Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development.

Prenatal alcohol exposure causes long-term serotonin neuron deficit in mice.

A neuroprotective peptide antagonizes fetal alcohol exposure-compromised brain growth.

Serotonin1B receptors: from protein to physiological function and behavior.

Fetal alcohol exposure reduces serotonin innervation and compromises development of the forebrain along the serotonergic pathway.

Effects of chronic alcohol and repeated deprivations on dopamine D1 and D2 receptor levels in the extended amygdala of inbred alcohol-preferring rats.

Structural and functional modifications in glutamateric synapses following prolonged ethanol exposure.

Brain deficits associated with fetal alcohol exposure may be protected, in part, by peptides derived from activity-dependent neurotrophic factor and activity-dependent neuroprotective protein.

Glutamate and dopamine synaptic terminals in extended amygdala after 14-week chronic alcohol drinking in inbred alcohol-preferring rats.

Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats.

Differential expression of proteins in fetal brains of alcohol-treated prenatally C57BL/6 mice: a proteomic investigation.

Alteration of selective neurotransmitters in fetal brains of prenatally alcohol-treated C57BL/6 mice: quantitative analysis using liquid chromatography/tandem mass spectrometry.

Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease.

Role of the serotonergic system in alcohol dependence: from animal models to clinics.

Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats.

Potential drugs and methods for preventing or delaying the progression of Huntington's disease.

Huntington's Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy.

Neuroprotective peptide ADNF-9 in fetal brain of C57BL/6 mice exposed prenatally to alcohol.

Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders.

Cilostazol prevents endothelin-induced smooth muscle constriction and proliferation.

Role of 5-hydroxytryptamine 1B (5-HT1B) receptors in the regulation of ethanol intake in rodents.

Neurotrophic peptides, ADNF-9 and NAP, prevent alcohol-induced apoptosis at midgestation in fetal brains of C57BL/6 mouse.

Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats.